President Donald Trump is launching a project that aims to fast-track the development of a coronavirus vaccine. Called “Operation Warp Speed,” its goal is to manufacture millions of doses of the vaccine by the end of the year, according to CNN.
“I hope we’re going to have a vaccine and we’re going to fast-track a vaccine like you’ve never seen before if we come with a vaccine,” Donald Trump said during a meeting with New Jersey Gov. Phil Murphy at the White House, CNBC reported. “I think they probably will.”
The project’s goal might appear a bit optimistic but Trump is confident that it can be done. “I’m not overpromising,” he said. “Whatever the maximum is, whatever you can humanly do, we’re going to do.”
Trump also said that he will personally oversee the project. “I’m really in charge of it,” the POTUS said. “I think probably more than anything I’m in charge.”
There are multiple projects all over the world working on creating a coronavirus vaccine but it might take some time before their efforts bear fruit. According to the National Institute of Allergy and Infectious Diseases director Dr. Anthony Fauci, a vaccine for the virus might take between a year and 18 months to develop.
However, Donald Trump said that in Operation Warp Speed, both government researchers and pharmaceutical firms will join forces to shorten the development time of the vaccine, a cooperation that has been described as a Manhattan Project-like effort. The Manhattan Project was a World War II led by the U.S. with support from the U.K. Canada to develop the first atomic bomb and end the war.
The U.S. has the highest number of COVID-19 cases worldwide with more than 1.1 million Americans infected with the virus, according to data from Worldometers. The country also has the highest number of casualties with more than 67,000 deaths due to the disease.
One positive development in the country’s fight against the pandemic is that Gilead Sciences’ antiviral drug remdesivir showed positive outcomes in initial trials. COVID-19 patients who took the drug recovered 30 percent faster than those who took a placebo.


TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Brazil, Spain, and Mexico Unite to Support Cuba Amid U.S. Blockade
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos
Iran-Lebanon War: Ceasefire Reached as U.S. and Iran Edge Closer to Nuclear Deal
North Korea Fires Multiple Ballistic Missiles Amid Growing Nuclear Ambitions
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Peru Election 2025: Vote Count Delays Spark Calls to Remove Electoral Chief
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
The four types of dementia most people don’t know exist
France and Britain Lead 40-Nation Talks to Reopen Strait of Hormuz
Myanmar Grants Amnesty to Over 4,000 Prisoners Under New President Min Aung Hlaing
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
China Navigates Diplomatic Tightrope Between Iran Peace Efforts and Trump Summit 



